Evidence map›Paper›PMID 41664581›Full record

ReviewFEBS letters2026

Conserved structural motifs in PAS, LOV, and CRY proteins regulate circadian rhythms and are therapeutic targets.

Eric D Brinckman, Anna E Lester, Brian D Zoltowski

Abstract readReview
In one paragraph

Review in FEBS letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eric D BrinckmanDepartment of Chemistry, Center for Drug Discovery, Design, and Delivery, Southern Methodist University, Dallas, TX, 75275, USA.
Anna E LesterDepartment of Chemistry, Center for Drug Discovery, Design, and Delivery, Southern Methodist University, Dallas, TX, 75275, USA.
Brian D ZoltowskiDepartment of Chemistry, Center for Drug Discovery, Design, and Delivery, Southern Methodist University, Dallas, TX, 75275, USA.ORCID 0000-0001-6749-0743

Funding

Structural Flexibility Mediates Circadian Adaptation in Diverse OrganismsR15GM109282 · NIGMS · SOUTHERN METHODIST UNIVERSITY · PI ZOLTOWSKI, BRIAN DAVID · 2014 to 2021
$1.2M
NIGMS NIH HHS R15GM109282Welch Foundation
6 · The paper itself

Abstract

Despite evolving independently in diverse organisms, circadian clocks ubiquitously employ period-ARNT-single minded (PAS) and cryptochrome (CRY) proteins as key regulators coupling environmental variables into circadian regulation. In these systems, we often observe complex gene duplication events and evolution of specialized function despite retaining high-sequence identity. These specialized functions often have evolved from ancestral photoactive proteins (LOV/CRY) where upon the ancestral photoactive ligand-binding pockets have been co-opted as protein-protein interaction motifs and targets for drug discovery. In this review, we dissect structural, biochemical, and computational studies of the PAS and CRY superfamilies within circadian clocks to highlight their molecular mechanisms and factors that position them as drug targets for diverse disease phenotypes. Particular focus is placed on discussing how photoactive members of the protein families can inform on allosteric mechanisms that couple cofactor-binding sites to regulation of flexible signaling motifs relevant to circadian regulation and drug discovery.

Indexed as

Circadian RhythmCryptochromesPeriod Circadian ProteinsAmino Acid MotifsAnimalsCircadian ClocksConserved SequenceHumansModels, MolecularCryptochromesPeriod Circadian Proteinscircadian clockcryptochromeLOV domainPAS domainphotoreceptor

Identifiers

PMID41664581
PMCPMC13022749

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.